α,β-Trehalose 10 mg | ≥95% Cayman Chemical A disaccharide More Information Supplier Page × α,β-Trehalose
5′-O-DMT-2′-O-methyl-Uridine-CE Phosphoramidite 25 g | ≥95% Cayman Chemical A nucleoside building block More Information Supplier Page × 5′-O-DMT-2′-O-methyl-Uridine-CE Phosphoramidite
5′-O-DMT-2′-O-methyl-Uridine-CE Phosphoramidite 1 g | ≥95% Cayman Chemical A nucleoside building block More Information Supplier Page × 5′-O-DMT-2′-O-methyl-Uridine-CE Phosphoramidite
5′-O-DMT-2′-O-methyl-Uridine-CE Phosphoramidite 10 g | ≥95% Cayman Chemical A nucleoside building block More Information Supplier Page × 5′-O-DMT-2′-O-methyl-Uridine-CE Phosphoramidite
D-Glucosaminic Acid 1 g | ≥98% Cayman Chemical An aldonic acid More Information Supplier Page × D-Glucosaminic Acid
D-Glucosaminic Acid 500 mg | ≥98% Cayman Chemical An aldonic acid More Information Supplier Page × D-Glucosaminic Acid
WEHI-539 (hydrochloride) 5 mg | ≥95% Cayman Chemical A Bcl-xL inhibitor More Information Supplier Page × WEHI-539 (hydrochloride)
WEHI-539 (hydrochloride) 1 mg | ≥95% Cayman Chemical A Bcl-xL inhibitor More Information Supplier Page × WEHI-539 (hydrochloride)
WEHI-539 (hydrochloride) 10 mg | ≥95% Cayman Chemical A Bcl-xL inhibitor More Information Supplier Page × WEHI-539 (hydrochloride)
VUF 11207 (fumarate) 50 mg | ≥98% Cayman Chemical A CXCR7 agonist More Information Supplier Page × VUF 11207 (fumarate)
